Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets

Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets

October 11, 2019

Kyowa Kirin, the sole manufacturers of Nardil (phenelzine sulfate) 15mg tablets, are currently experiencing temporary disruptions.

Kyowa Kirin, the main supplier of Nardil (phenelzine sulfate) 15mg tablets have advised a delayed resupply date of March 2020. Supplies are available from specialist importers on an ‘unlicensed’ basis, and these companies listed below have advised they can continue to source unlicensed imports from abroad but the list is not exhaustive.

Ensure that where a prescriber wishes you to dispense an import, prescriptions are annotated ‘specials/unlicensed’ and are endorsed as follows:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

SPS website which UK Medicine Information previously published about  management options including the need for specialist referral to mental health teams if unlicensed supplies of phenelzine sulfate 15mg tablets are deemed unsuitable



Posted in:


More Latest News >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...

PQS: NSAID quality criterion

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS)...